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receptor variants in the human population. Nature 358:Thus, we were not able to replicate the ﬁndings of
149–152Grice et al. (1996).
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To the Editor:
Atypical vitelliform macular dystrophy (VMD1; OMIM
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syndrome, by the transmission-disequilibrium test. Am J able (Mintz-Hittner et al. 1984).
Hum Genet 59:644–652 An early linkage study in one large family reported
Hebebrand J, No¨then MM, Lehmkuhl G, Poustka F, Schmidt linkage between the VMD1 locus and the soluble gluta-
M, Propping P, Remschmidt H (1993) Tourette’s syndrome mate-pyruvate transaminase (GPT) locus, with a maxi-
and homozygosity for the dopamine D3 receptor gene. Lan- mum two-point LOD score of 4.3 at 5% recombination
cet 341:1483 (Ferrell et al. 1983). At that time, the GPT locus had
Lichter JB, Barr CL, Kennedy JL, Van Tol HHM, Kidd KK,
been mapped tentatively to chromosome 16 (Wijnen andLivak KJ (1993) A hypervariable segment in the human
Meera Khan 1982). Recently, however, we have mappeddopamine receptor D4 (DRD4) gene. Hum Mol Genet 2:
the GPT locus to the long arm of chromosome 8 and767–773
have developed a PCR-RFLP assay for GPT typing (So-No¨then MM, Cichon S, Hemmer S, Hebebrand J, Remschmidt
hocki et al. 1997). All previous GPT typing was by deter-H, Lehmkuhl G, Poustka F, et al (1994a) Human dopamine
D4 receptor gene: frequent occurrence of a null allele and obser- mination of the serologic phenotype only, and, because
vation of homozygosity. Hum Mol Genet 3:2207–2212 there are dramatic quantitative differences between the
No¨then MM, Hebebrand J, Knapp M, Hebebrand K, Camps three common GPT serologic phenotypes (Welch 1972),
A, von Gontard A, Wettke-Scha¨fer R, et al (1994b) Associa- GPT serotyping was difﬁcult. Furthermore, within the
tion analysis of the dopamine D2 receptor gene in Tourette’s last 4 years, several other loci associated with autosomal
syndrome using the haplotype relative risk method. Am J dominant macular degeneration (adMD) have been
Med Genet 54:249–252
mapped to chromosomal sites (table 1). Given the re-Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission
ﬁned localization of the GPT locus and given the addi-test for linkage disequilibrium: the insulin gene region and
tional mapped loci for adMD, it was important to re-insulin-dependent diabetes mellitus (IDDM). Am J Hum
examine the localization of the VMD1 locus in the pre-Genet 52:506–516
viously studied family.Van Tol HHM, Wu CM, Guan H-C, Ohara K, Bunzow JR,
Civelli O, Kennedy J, et al (1992) Multiple dopamine D4 To further characterize the VMD1 locus, we recently
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Table 1
Two-Point LOD Scores between the VMD1 Locus and Candidate Loci
LOD SCORE AT RECOMBINATION FRACTION
CANDIDATE CHROMOSOMAL
DISEASE/GENEa LOCALIZATION MARKER .00 .01 .05 .10 .20 .30 .40 REFERENCE
VMD1 8q24.3b D8S315 038.2 015.5 08.29 04.91 01.9 0.63 0.11 Leach et al. 1996
VMD1 8q24.3b GPT 03.04 01.19 0.50 0.23 0.04 .00 0.01 Ferrell et al. 1983
VMD1 8q24.3b D8S1925 08.90 05.60 03.00 01.50 0.12 .24 .21 Leach et al. 1996
STGD1, FFM 1p21-p13 D1S188 09.75 05.74 02.76 01.47 0.42 0.03 .07 Gerber et al. 1995
RDS 6p21.1-cen D6S271 010.5 06.72 03.46 02.05 0.92 0.48 0.25 Dib et al. 1996
STGD3 6q11-q15 D6S280 03.35 02.64 01.33 0.75 0.27 0.08 0.00 Stone et al. 1994
MCDR1 6q14-q16.2 D6S1717 03.58 02.35 0.92 0.32 .07 .11 .31 Small et al. 1992
CYMD, DCMD 7p21-p15 D7S435 011.5 06.30 03.22 01.90 0.70 0.16 .04 Kremer et al. 1994
VMD2 11q13 D11S480 010.0 07.09 04.04 02.52 01.14 0.51 0.18 Graff et al. 1994
STGD2 13q34 D13S158 017.1 09.12 04.92 02.83 01.07 0.34 0.05 Zhang et al. 1994
RCD2 17p13 D17S796 010.8 07.04 03.29 01.77 0.56 0.14 0.01 Small et al. 1996
CORD2 19q13.3-q13.4 D19S49 09.71 06.28 03.24 01.95 0.86 0.38 0.13 Evans et al. 1994
SFD, TIMP3 22q12.1-q13.2 D22S304 011.7 08.12 04.37 02.75 01.28 0.56 0.17 Wijesuriya et al. 1996;
Weber et al. 1994
a STGD1 Å Stargardt disease; FFM Å fundus ﬂavimaculatus; RDS Å retinal degeneration slow; STGD3 Å Stargardt disease 3; MCDR1
Å dominant North Carolina macular dystrophy; CYMD Å cystoid macular dystrophy; DCMD Å dominant cystoid macular dystrophy; STGD2
Å Stargardt disease 2, macular dystrophy with ﬂecks, type 2; RCD2 Å retinal cone dystrophy 2; CORD2 Å cone-rod retinal dystrophy; SFD
Å fundus dystrophy, pseudoinﬂammatory, of Sorsby; and TIMP3 Å tissue inhibitor of metalloproteinases-3.
b As reported prior to this study.
updated the clinical information for the original family highly unlikely that the VMD1 locus maps to the
known adMD loci.and collected new blood samples. The family was typed
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